Latest News

Earnings Results: Amgen’s Q4 tops views, but 2023 guidance falls on lower end of expectations

Amgen Inc. topped Wall Street expectations for its fourth quarter, but the drug maker’s shares fell after hours as its 2023 guidance fell on the lower end of Wall Street’s expectations. 

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Latest News